Continuum Advisory’s DexCom DXCM Stock Holding History

Continuum Advisory’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$77.2K	Buy	+1,146	New	+$76.4K	0.01%	698
2025 Q2	–	Sell	-280	Closed	-$19.1K	–	713
2025 Q1	$19.1K	Sell	280 -15	-5%	-$1.22K	﹤0.01%	865
2024 Q4	$22.9K	Buy	295 +2	+0.7%	+$148	﹤0.01%	818
2024 Q3	$21.9K	Buy	293 +32	+12%	+$2.63K	﹤0.01%	822
2024 Q2	$29.6K	Buy	261 +4	+2%	+$506	﹤0.01%	719
2024 Q1	$32.9K	Buy	+257	New	+$32.3K	﹤0.01%	681
2023 Q3	–	Sell	-1,630	Closed	-$209K	–	457
2023 Q2	$209K	Buy	+1,630	New	+$197K	0.03%	426
2022 Q1	–	Sell	-1,668	Closed	-$224K	–	382
2021 Q4	$224K	Buy	1,668 +12	+0.7%	+$1.72K	0.05%	275
2021 Q3	$226K	Buy	+1,656	New	+$209K	0.06%	269

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Continuum Advisory's DXCM Position: Q2 2026 in Review

Continuum Advisory opened a new position in DexCom (DXCM) in Q2 2026: 1,146 shares worth $77.2K. The stake represents 0.01% of the portfolio and ranks #698 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in DXCM as recently as Q1 2025.

Continuum Advisory first reported a position in DXCM in Q3 2021 and has held it in 9 quarters since. The position peaked at $226K in Q3 2021. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Continuum Advisory held 1,146 shares of DexCom worth $77.2K as of Q2 2026.
DexCom was a new Continuum Advisory position in Q2 2026.
DexCom made up 0.01% of Continuum Advisory's portfolio in Q2 2026, its #698 holding.
Continuum Advisory first reported a position in DexCom in Q3 2021 and has held it in 9 quarters since.
Continuum Advisory's DexCom position peaked at $226K in Q3 2021.
973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.